India has a significant share in the global generics market and is ranked third in the world. Three factors favoring the company’s manufacturing hub in India are a strong marketing set up, low prices and the advantage of using the English language. With domestic drug sales of almost $5 billion, Indian companies have also developed a considerable service industry for the global pharmaceutical market.
Emerging Markets – Focus on High Growth
Growth is shifting away from developed markets in the U.S. and Europe and toward emerging markets as less developed countries prosper and spend more money on health care.
SOHM’s Growth Strategy – Emerging Markets Leader
Increasing SOHM’s market share in key markets, including an extension of its leadership position in the world’s emerging generic pharmaceutical markets in Africa, Latin America, and Southeast Asia and other important international markets.
SOHM Announces Acquisition of Novatrend
Rapidly responding to customers’ most significant needs by – among others—broadening SOHM’s product portfolio and executing an increasing number of launches, optimizing a truly global supply chain, helping customers more efficiently manage their inventory and customizing shipping methods based on specific customer needs.